Inactive Instrument
Epigenomics AG Stock Deutsche Boerse AG
Stocks
DE000A0BVT96
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Deutsche Boerse AG
|
||
| - EUR | - |
|
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 25-07-22 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 802K 935K 753K 688K 1.3M 89.17M 1.3M 8.91M 3.45M 44.99M 3.51M 3.43M 149M | P/E 2024 |
-0.29x | P/E 2025 | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 11.77M 13.71M 11.05M 10.09M 19.04M 1.31B 19.13M 131M 50.66M 660M 51.49M 50.37M 2.19B | EV / Sales 2024 |
-
| EV / Sales 2025 | 490x |
| Free-Float |
70.75% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | 55 | 2024-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Helge Lubenow
CHM | Chairman | 58 | 2023-02-28 |
Alexander Link
BRD | Director/Board Member | 55 | 2020-05-31 |
Jochen Hummel
BRD | Director/Board Member | 56 | 2024-02-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.34% | +2.63% | +104.38% | +324.68% | 4.18B | |
| -4.27% | +1.13% | +229.80% | +31.38% | 3.66B | |
| +0.57% | +4.98% | +52.36% | +74.16% | 3.56B | |
| +0.31% | +9.57% | +297.81% | +483.73% | 2.64B | |
| -2.91% | +4.01% | -26.20% | -20.95% | 2.33B | |
| +1.52% | +2.64% | +32.48% | - | 1.51B | |
| -1.11% | +23.27% | +267.77% | -14.42% | 1.33B | |
| -2.18% | +3.80% | +19.81% | +45.60% | 1.06B | |
| +1.68% | +22.01% | +34.48% | +180.72% | 679M | |
| Average | -0.21% | +9.24% | +112.52% | +138.11% | 2.33B | |
| Weighted average by Cap. | -0.17% | +6.43% | +125.92% | +160.28% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 24K 27.96K 22.53K 20.57K 38.83K 2.67M 39.02K 267K 103K 1.35M 105K 103K 4.46M |
| Net income | -3.35M -3.91M -3.15M -2.87M -5.42M -372M -5.45M -37.23M -14.43M -188M -14.66M -14.35M -622M | -314K -366K -295K -269K -508K -34.89M -510K -3.49M -1.35M -17.6M -1.37M -1.34M -58.3M |
| Net Debt | 10.46M 12.18M 9.81M 8.96M 16.91M 1.16B 17M 116M 45.01M 586M 45.74M 44.74M 1.94B | 10.97M 12.78M 10.29M 9.4M 17.74M 1.22B 17.83M 122M 47.21M 615M 47.98M 46.93M 2.04B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
